| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total revenues | 102,871 | 98,915 | 94,588 | 95,428 |
| Cost of products sold | 57,045 | 54,005 | 51,057 | 52,948 |
| Health care costs | 32,020 | 31,317 | 29,135 | 29,922 |
| Operating expenses | 11,288 | 11,212 | 11,022 | 10,557 |
| Goodwill impairment | 5,725 | - | - | - |
| Restructuring charges | 0 | - | - | 1,169 |
| Loss on assets held for sale | - | - | - | 0 |
| Total operating costs | 106,078 | 96,534 | 91,214 | 94,596 |
| Operating income (loss) | -3,207 | 2,381 | 3,374 | 832 |
| Gain on deconsolidation of subsidiary | 483 | - | - | - |
| Interest expense | 784 | 763 | 785 | 752 |
| Other income | 26 | 29 | 28 | 25 |
| Income (loss) before income tax provision | -3,482 | 1,647 | 2,617 | 105 |
| Income tax provision | 508 | 634 | 835 | 34 |
| Net income (loss) | -3,990 | 1,013 | 1,782 | 71 |
| Net loss attributable to noncontrolling interests | -15 | -8 | 3 | -16 |
| Net income (loss) attributable to cvs health | -3,975 | 1,021 | 1,779 | 87 |
| Basic (in dollars per share) | -3.13 | 0.81 | 1.41 | 0.07 |
| Basic (in shares) | 1,269,000,000 | 1,266,000,000 | 1,261,000,000 | 1,259,000,000 |
| Diluted (in dollars per share) | -3.13 | 0.8 | 1.41 | 0.07 |
| Diluted (in shares) | 1,269,000,000 | 1,270,000,000 | 1,264,000,000 | 1,259,000,000 |
CVS HEALTH Corp (CVS)
CVS HEALTH Corp (CVS)